Extended Research Article
A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trial
Sube Banerjee
,
Nicolas Farina
,
Catherine Henderson
,
Juliet High
,
Susan Stirling
,
Lee Shepstone
et al.
-
Journal:
Health Technology Assessment Volume: 27, Issue: 23
-
Published:
31 October 2023